Vanda Pharmaceuticals
VNDA
#7542
Rank
$0.39 B
Marketcap
$6.75
Share price
11.39%
Change (1 day)
46.74%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - P/B ratio

P/B ratio as of December 2025 : 0.8560

According to Vanda Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 1.88096.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Vanda Pharmaceuticals - P/B ratio (from 2006 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-310.520816.88%
2023-12-310.4456-43.83%
2022-12-310.7933-54.18%
2021-12-311.738.84%
2020-12-311.59-25.62%
2019-12-312.14-57.05%
2018-12-314.98-4.21%
2017-12-315.20-2.62%
2016-12-315.3478.12%
2015-12-313.00-18.89%
2014-12-313.69-60.6%
2013-12-319.38-11.12%
2012-12-3110.5163.86%
2011-12-314.00-43.13%
2010-12-317.03-47.79%
2009-12-3113.54550.29%
2008-12-310.2896-86.78%
2007-12-312.19-89.26%
2006-12-3120.4
2005-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
5.62 557.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
37.3 4,262.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.28 633.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.60 554.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.57 83.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
2.20 156.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.70 448.76%๐Ÿ‡บ๐Ÿ‡ธ USA